Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

95.01
+2.252.43%
Post-market: 95.010.00000.00%19:30 EDT
Volume:86.82K
Turnover:8.23M
Market Cap:1.39B
PE:-10.70
High:95.81
Open:92.70
Low:92.70
Close:92.76
52wk High:155.29
52wk Low:28.16
Shares:14.67M
Float Shares:8.59M
Volume Ratio:0.43
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8768
EPS(LYR):-9.0434
ROE:-1773.60%
ROA:-43.61%
PB:-26.31
PE(LYR):-10.51

Loading ...

Inhibrx Biosciences Inc: Also Plans to Explore Potential of Inbrx-106 in Combination with Therapeutic Cancer Vaccines

THOMSON REUTERS
·
Sep 08

Inhibrx's Inbrx-106 Nearly Doubles Response Rate and Achieves Interim Median Pfs of 9.6 Months in Phase 2 Hnscc Study

THOMSON REUTERS
·
Sep 08

NASDAQ Trade Halt Halt News Pending at 07:25 Am

Reuters
·
Sep 08

Inhibrx Schedules Sept. 8 Webcast to Release Phase 2 INBRX-106 First-Line HNSCC Study Endpoint Results

Reuters
·
Sep 05

Inhibrx Biosciences Price Target Announced at $245.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 24

Inhibrx Biosciences, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $245

THOMSON REUTERS
·
Aug 24

Inhibrx Biosciences (INBX) Earnings Put Its Valuation Back In Focus

Simply Wall St.
·
Aug 22

Buy Rating Reaffirmed on Inhibrx Ahead of Key INBRX-106 Phase 2 Readout; $230 Price Target Maintained

TIPRANKS
·
Aug 15

Inhibrx Falls on Wider-than-Expected Quarterly Loss

Reuters
·
Aug 14

Inhibrx Biosciences Q2 EPS $(2.34) Beats $(2.39) Estimate

Benzinga Earnings
·
Aug 14

Inhibrx Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Inhibrx Biosciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 14

Inhibrx Net Loss Widens 27.9% to $36.7 Million in Q2 FY26; Revenue is no Revenue

Reuters
·
Aug 14

Inhibrx Q2 Operating Expenses USD 32.149 Million

THOMSON REUTERS
·
Aug 14

Does Inhibrx Biosciences' (INBX) Expanded Credit Facility Quietly Redefine Its Risk‑Reward Profile?

Simply Wall St.
·
Jul 23

Inhibrx Shares Fall After Expanding Loan Agreement to $500M

Dow Jones
·
Jul 16

Inhibrx Biosciences Expands Oxford Finance Loan Facility to USD 500 Million

Reuters
·
Jul 16

Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million

THOMSON REUTERS
·
Jul 16

Inhibrx Biosciences - Second Amendment Adds up to $325 Mln, Including $100 Mln Funded and $225 Mln Available

THOMSON REUTERS
·
Jul 16

Inhibrx Biosciences (INBX) Following Russell Reshuffle With Valuation Still Hard To Pin Down

Simply Wall St.
·
Jul 08